Herpes simplex virus and HIV-1: deciphering viral synergy

The Lancet Infectious Diseases

Volumn 9, Issue 2, 2009, Pages 74-

  Cheng, Rex G ^a   Nixon, Douglas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; COTRIMOXAZOLE;

CD4 LYMPHOCYTE COUNT; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMODULATION; IMMUNOSTIMULATION; INFECTION CONTROL; INFECTION PREVENTION; LETTER; MIXED INFECTION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; T CELL DEPLETION; VIRUS INHIBITION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS SHEDDING; HERPES SIMPLEX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; NOTE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VIROLOGY;

HERPES SIMPLEX; HIV INFECTIONS; HIV-1; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIMPLEXVIRUS; VIRUS SHEDDING;

EID: 58549114440     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(09)70002-7     Document Type: Letter

References (10)

1. Van de Perre P., Segondy M., Foulongne V., et al. Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis 8 (2008) 490-497
2. Cowan F.M., Pascoe S., Barlow K., et al. A randomised placebo controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers. Sex Transm Infect 84 (2008) 548-553
3. Watson-Jones D., Weiss H.A., Rusizoka M., et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 358 (2008) 1560-1571
4. Barbour J.D., Sauer M.M., Sharp E.R., et al. HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts. PLoS ONE 2 (2007) e1080
5. Zachariah R., Harries A.D., Luo C., Bachman G., and Graham S.M. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. Lancet Infect Dis 7 (2007) 686-693
6. Xiang J., Wunschmann S., Diekema D.J., et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345 (2001) 707-714
7. Van der Bij A.K., Kloosterboer N., Prins M., et al. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis 191 (2005) 678-685
8. Kaye S., Howard M., Alabi A., Hansmann A., Whittle H., and van der Loeff M.S. No observed effect of GB virus C coinfection on disease progression in a cohort of African woman infected with HIV-1 or HIV-2. Clin Infect Dis 40 (2005) 876-878
9. Ryt-Hansen R., Katzenstein T.L., Gerstoft J., and Eugen-Olsen J. No influence of GB virus C on disease progression in a Danish cohort of HIV-infected men. AIDS Res Hum Retroviruses 22 (2006) 496-498
10. Stapleton J.T., Xiang J., and Williams C.F. HIV and GB virus C coinfection. Lancet Infect Dis 6 (2006) 187-188